Clinical Trials Directory

Trials / Conditions / Recurrent High-grade Glioma

Recurrent High-grade Glioma

19 registered clinical trials studyying Recurrent High-grade Glioma — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingDual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
NCT07480941
Beijing BiotechPhase 1
Active Not RecruitingPeds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Gra
NCT07031765
University of FloridaPhase 1
WithdrawnA Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma
NCT06501911
University of NebraskaPhase 1
Active Not RecruitingRNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors
NCT05660408
University of FloridaPhase 1 / Phase 2
Enrolling By InvitationEvaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.
NCT06763965
Beijing Bio-Targeting Therapeutics Technology Co., LtdPhase 1 / Phase 2
WithdrawnStudy to Assess Xevinapant in Preoperative Subjects With Recurrent High-Grade Glioma (rHGG)
NCT06463184
H. Lee Moffitt Cancer Center and Research InstitutePhase 1
RecruitingOpen-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252
NCT06126744
Duke UniversityPhase 1
RecruitingCD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in
NCT06305910
OX2 TherapeuticsPhase 1
RecruitingRecurrent High Grade Glioma Treated by LITT
NCT06161610
Beijing Tiantan HospitalN/A
RecruitingA Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
NCT05698524
University of NebraskaPhase 1
TerminatedStudying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-gra
NCT05737212
Dawonmedax Co., Ltd.Phase 1 / Phase 2
Active Not RecruitingPTCs-based Precision Treatment Strategy on Recurrent High-grade Gliomas
NCT05473923
Beijing Tiantan HospitalEARLY_Phase 1
TerminatedAsiDNA Children, Adolescents and Young Adults
NCT05394558
Institut CuriePhase 1 / Phase 2
UnknownNeoadjuvant Carilizumab and Apatinib for Recurrent High-Grade Glioma
NCT04588987
Sun Yat-sen UniversityPhase 2
UnknownA Study of Anlotinib in the Treatment of Recurrent High-grade Glioma
NCT04822805
First People's Hospital of HangzhouPhase 2
CompletedHypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma
NCT02567539
Istituto Clinico HumanitasN/A
UnknownUltra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas
NCT02416999
Hebei Yanda HospitalN/A
UnknownA Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Gli
NCT02333513
Hebei Yanda HospitalN/A
CompletedA Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Col
NCT01172964
City of Hope Medical CenterPhase 1